

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.44741034 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72891409 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.55402625 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.40743772 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34242632 |
| 6 | glutamate secretion (GO:0014047) | 5.30337981 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.25891068 |
| 8 | vocalization behavior (GO:0071625) | 5.15738019 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.05697693 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.95066320 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.59681029 |
| 12 | layer formation in cerebral cortex (GO:0021819) | 4.59667853 |
| 13 | protein localization to synapse (GO:0035418) | 4.57659158 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.52575376 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.50216598 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.38766531 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.32873507 |
| 18 | exploration behavior (GO:0035640) | 4.32211973 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.30008276 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.26359769 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.18660042 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.17892449 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.12289627 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 4.02556289 |
| 25 | response to peptidoglycan (GO:0032494) | 3.94795394 |
| 26 | proline transport (GO:0015824) | 3.89494286 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.82133008 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.80027001 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.77592180 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77592180 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.77349080 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 3.76546897 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.70088925 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.67521055 |
| 35 | sodium ion export (GO:0071436) | 3.60622425 |
| 36 | long-term memory (GO:0007616) | 3.60059668 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.58891941 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.58623006 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.55560559 |
| 40 | L-amino acid import (GO:0043092) | 3.55490770 |
| 41 | glycine transport (GO:0015816) | 3.55111750 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.54414571 |
| 43 | neuromuscular process controlling balance (GO:0050885) | 3.53756354 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.51132821 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.48997578 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.45268073 |
| 47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44826063 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.43208655 |
| 49 | neurotransmitter transport (GO:0006836) | 3.41818633 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.38614185 |
| 51 | neuron recognition (GO:0008038) | 3.38038182 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.37689140 |
| 53 | mannose metabolic process (GO:0006013) | 3.33222808 |
| 54 | establishment of mitochondrion localization (GO:0051654) | 3.33070629 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.32864196 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30905608 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29841840 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.28900427 |
| 59 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28807803 |
| 60 | dendrite morphogenesis (GO:0048813) | 3.27852100 |
| 61 | central nervous system myelination (GO:0022010) | 3.27839054 |
| 62 | axon ensheathment in central nervous system (GO:0032291) | 3.27839054 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.27811149 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.26534791 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.25509877 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.23816817 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.23351419 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.23351419 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 3.23351419 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.23351419 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.23351419 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.23351419 |
| 73 | vesicle transport along microtubule (GO:0047496) | 3.22410661 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 3.20709575 |
| 75 | adult walking behavior (GO:0007628) | 3.20500683 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19490468 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16733937 |
| 78 | regulation of ARF protein signal transduction (GO:0032012) | 3.16671597 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.16304691 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 3.16304691 |
| 81 | positive regulation of synapse maturation (GO:0090129) | 3.15939869 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15870808 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 3.15425606 |
| 84 | nerve growth factor signaling pathway (GO:0038180) | 3.15014767 |
| 85 | organelle transport along microtubule (GO:0072384) | 3.14865613 |
| 86 | regulation of dendritic spine development (GO:0060998) | 3.13270840 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 3.12541951 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12487631 |
| 89 | neutrophil activation (GO:0042119) | 3.12476438 |
| 90 | auditory behavior (GO:0031223) | 3.11841367 |
| 91 | negative regulation of microtubule polymerization (GO:0031115) | 3.11692790 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09595518 |
| 93 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.09419758 |
| 94 | long-term synaptic potentiation (GO:0060291) | 3.08941160 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08836317 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 3.08236804 |
| 97 | detection of other organism (GO:0098543) | 3.07137798 |
| 98 | granulocyte activation (GO:0036230) | 3.06993027 |
| 99 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.05752565 |
| 100 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05302051 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 3.05183621 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04137455 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04101710 |
| 104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02631965 |
| 105 | response to auditory stimulus (GO:0010996) | 3.02273507 |
| 106 | clathrin coat assembly (GO:0048268) | 3.01557049 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 3.00914468 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 3.00361621 |
| 109 | detection of bacterium (GO:0016045) | 2.99741533 |
| 110 | neuromuscular process controlling posture (GO:0050884) | 2.99700490 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.97338006 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.97289629 |
| 113 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.95228645 |
| 114 | axonal fasciculation (GO:0007413) | 2.94971490 |
| 115 | neuronal ion channel clustering (GO:0045161) | 2.94223169 |
| 116 | leukocyte aggregation (GO:0070486) | 2.93868737 |
| 117 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92727230 |
| 118 | positive regulation of neurotransmitter transport (GO:0051590) | 2.91882134 |
| 119 | prepulse inhibition (GO:0060134) | 2.91825911 |
| 120 | membrane hyperpolarization (GO:0060081) | 2.91558295 |
| 121 | axon cargo transport (GO:0008088) | 2.90989092 |
| 122 | membrane depolarization (GO:0051899) | 2.90901434 |
| 123 | presynaptic membrane organization (GO:0097090) | 2.89119057 |
| 124 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.88936008 |
| 125 | signal complex assembly (GO:0007172) | 2.88512908 |
| 126 | cell migration in hindbrain (GO:0021535) | 2.86872609 |
| 127 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86800752 |
| 128 | mating behavior (GO:0007617) | 2.85106507 |
| 129 | postsynaptic membrane organization (GO:0001941) | 2.85095379 |
| 130 | learning (GO:0007612) | 2.84939172 |
| 131 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.84783015 |
| 132 | neuromuscular process (GO:0050905) | 2.84770866 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.84642674 |
| 134 | presynaptic membrane assembly (GO:0097105) | 2.84167682 |
| 135 | mitochondrion transport along microtubule (GO:0047497) | 2.83579041 |
| 136 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.83579041 |
| 137 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.83522754 |
| 138 | dendritic spine organization (GO:0097061) | 2.83456616 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81187961 |
| 140 | immunoglobulin mediated immune response (GO:0016064) | 2.80062045 |
| 141 | detection of molecule of bacterial origin (GO:0032490) | 2.77932795 |
| 142 | detection of external biotic stimulus (GO:0098581) | 2.76126216 |
| 143 | response to acidic pH (GO:0010447) | 2.67543407 |
| 144 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.65734726 |
| 145 | positive regulation of regulated secretory pathway (GO:1903307) | 2.65499256 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64106461 |
| 147 | positive regulation of Rap GTPase activity (GO:0032854) | 2.63298535 |
| 148 | positive regulation of type 2 immune response (GO:0002830) | 2.61990215 |
| 149 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.58646179 |
| 150 | response to type I interferon (GO:0034340) | 2.56453933 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.55920489 |
| 152 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.55702064 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.55557249 |
| 154 | cellular response to type I interferon (GO:0071357) | 2.55418112 |
| 155 | type I interferon signaling pathway (GO:0060337) | 2.55418112 |
| 156 | regulation of mast cell activation (GO:0033003) | 2.53382184 |
| 157 | * regulation of ARF GTPase activity (GO:0032312) | 2.49639794 |
| 158 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.49620677 |
| 159 | amino acid import (GO:0043090) | 2.49045357 |
| 160 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49045003 |
| 161 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48630251 |
| 162 | regulation of podosome assembly (GO:0071801) | 2.48339255 |
| 163 | activation of MAPKKK activity (GO:0000185) | 2.47806205 |
| 164 | regulation of T cell tolerance induction (GO:0002664) | 2.45774322 |
| 165 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.44795699 |
| 166 | germinal center formation (GO:0002467) | 2.44776295 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.44101816 |
| 168 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43291215 |
| 169 | macrophage activation (GO:0042116) | 2.42918569 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.40618248 |
| 171 | cerebellar granule cell differentiation (GO:0021707) | 2.39845958 |
| 172 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.38468971 |
| 173 | detection of biotic stimulus (GO:0009595) | 2.37502267 |
| 174 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35636269 |
| 175 | regulation of synapse maturation (GO:0090128) | 2.29908850 |
| 176 | regulation of female gonad development (GO:2000194) | 2.28704897 |
| 177 | regulation of tolerance induction (GO:0002643) | 2.26565041 |
| 178 | respiratory burst (GO:0045730) | 2.24851519 |
| 179 | cell-cell junction maintenance (GO:0045217) | 2.21835855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.38894832 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05126316 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.03464797 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92432460 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90929694 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.88753147 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.83121149 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80637291 |
| 9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61526451 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.61339061 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57841247 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55093523 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55093523 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.49768922 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45275378 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44445500 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42432338 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41582770 |
| 19 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.38335680 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.37350651 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28502593 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28066110 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27232912 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22396886 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19227570 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13125286 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11112252 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98605672 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91242491 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89459852 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.88107546 |
| 32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86958665 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86243510 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84880198 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83868620 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74917928 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71975958 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71512318 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68983189 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68438578 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67566582 |
| 42 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.66543005 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.62546161 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.61500877 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59957712 |
| 46 | * P68_20966046_ChIP-Seq_HELA_Human | 1.58716494 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57346850 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55566355 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54493472 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54402410 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53858159 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53237646 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52463970 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52286500 |
| 55 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50530964 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.49630862 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48202987 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44174807 |
| 59 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.43396718 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42167208 |
| 61 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.41903793 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40481073 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39861799 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.36857636 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34533864 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34157107 |
| 67 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33349892 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33067935 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32907895 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32745148 |
| 71 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32672429 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32151143 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32030381 |
| 74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31977760 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31196375 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31158798 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31059866 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29337188 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27958818 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27184932 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27166933 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26761348 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26478635 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25870664 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.24687287 |
| 86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24654132 |
| 87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23763980 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22886616 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22777366 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22486858 |
| 91 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21740668 |
| 92 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.21586001 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20844248 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20379429 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20183956 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18594862 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16764235 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16675125 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14838015 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14795396 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13951951 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12892223 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12872397 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12422564 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11769129 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11335737 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10138863 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09391535 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08746604 |
| 110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08446691 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 1.07422575 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07004383 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06789272 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06292926 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05819122 |
| 116 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05147416 |
| 117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04535896 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04300420 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03829866 |
| 120 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03471155 |
| 121 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02919928 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02364309 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02191258 |
| 124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02188508 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00875450 |
| 126 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00753361 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99968280 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99920481 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99187914 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98154206 |
| 131 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98053886 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97772778 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96913222 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96597168 |
| 135 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96446977 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95733858 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95533775 |
| 138 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94991886 |
| 139 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94785487 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93649412 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93622311 |
| 142 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93225814 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92726000 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92507025 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91375451 |
| 146 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91306192 |
| 147 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90576449 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88166949 |
| 149 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87067808 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86405232 |
| 151 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85564883 |
| 152 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84733393 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84186855 |
| 154 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84112659 |
| 155 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83380710 |
| 156 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83373211 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83139924 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82712795 |
| 159 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82614984 |
| 160 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82542947 |
| 161 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82537272 |
| 162 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82372108 |
| 163 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80056899 |
| 164 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79669007 |
| 165 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78425600 |
| 166 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78364325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.78395788 |
| 2 | MP0003880_abnormal_central_pattern | 4.84738838 |
| 3 | MP0004270_analgesia | 4.35889933 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.12819052 |
| 5 | MP0009745_abnormal_behavioral_response | 3.30708041 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.28633479 |
| 7 | MP0002064_seizures | 3.26063791 |
| 8 | MP0003436_decreased_susceptibility_to | 3.13395328 |
| 9 | MP0009046_muscle_twitch | 3.05802405 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.05337465 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.96023373 |
| 12 | MP0006082_CNS_inflammation | 2.86391648 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.81559288 |
| 14 | MP0002822_catalepsy | 2.70057803 |
| 15 | MP0003329_amyloid_beta_deposits | 2.68755681 |
| 16 | MP0002272_abnormal_nervous_system | 2.66579929 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.66129738 |
| 18 | MP0001486_abnormal_startle_reflex | 2.60391418 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.46008396 |
| 20 | MP0003724_increased_susceptibility_to | 2.39088801 |
| 21 | MP0002736_abnormal_nociception_after | 2.37676623 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.35906800 |
| 23 | MP0004858_abnormal_nervous_system | 2.25878395 |
| 24 | MP0001970_abnormal_pain_threshold | 2.23473614 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.22130885 |
| 26 | MP0005025_abnormal_response_to | 2.16351011 |
| 27 | MP0005671_abnormal_response_to | 2.10741705 |
| 28 | MP0002419_abnormal_innate_immunity | 2.07240874 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.07202098 |
| 30 | MP0001440_abnormal_grooming_behavior | 2.05404753 |
| 31 | MP0000920_abnormal_myelination | 2.04619097 |
| 32 | MP0005000_abnormal_immune_tolerance | 2.00368391 |
| 33 | MP0008569_lethality_at_weaning | 1.93157575 |
| 34 | MP0000778_abnormal_nervous_system | 1.91507099 |
| 35 | MP0009785_altered_susceptibility_to | 1.90983779 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.90188503 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.90093520 |
| 38 | MP0001790_abnormal_immune_system | 1.89379289 |
| 39 | MP0005387_immune_system_phenotype | 1.89379289 |
| 40 | MP0001800_abnormal_humoral_immune | 1.85664048 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.83135874 |
| 42 | MP0009278_abnormal_bone_marrow | 1.82537347 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.74662766 |
| 44 | MP0002723_abnormal_immune_serum | 1.74434156 |
| 45 | MP0000604_amyloidosis | 1.72431968 |
| 46 | MP0000955_abnormal_spinal_cord | 1.71403483 |
| 47 | MP0004924_abnormal_behavior | 1.71079468 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.71079468 |
| 49 | MP0004885_abnormal_endolymph | 1.69021835 |
| 50 | MP0005451_abnormal_body_composition | 1.68937311 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.66454716 |
| 52 | MP0003633_abnormal_nervous_system | 1.63631254 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.62565621 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.60809046 |
| 55 | MP0002184_abnormal_innervation | 1.60520274 |
| 56 | MP0001819_abnormal_immune_cell | 1.59872239 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.56121781 |
| 58 | MP0000685_abnormal_immune_system | 1.53930143 |
| 59 | MP0004947_skin_inflammation | 1.53870593 |
| 60 | MP0003690_abnormal_glial_cell | 1.53250828 |
| 61 | MP0003866_abnormal_defecation | 1.51975165 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.50045891 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.49922129 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.49494881 |
| 65 | MP0003879_abnormal_hair_cell | 1.46801981 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.44989407 |
| 67 | MP0003631_nervous_system_phenotype | 1.43350433 |
| 68 | MP0001905_abnormal_dopamine_level | 1.41192185 |
| 69 | MP0003075_altered_response_to | 1.39987850 |
| 70 | MP0008260_abnormal_autophagy | 1.39411564 |
| 71 | MP0004142_abnormal_muscle_tone | 1.39186942 |
| 72 | MP0004510_myositis | 1.38673045 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.34937104 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.34884644 |
| 75 | MP0003634_abnormal_glial_cell | 1.32846267 |
| 76 | MP0003303_peritoneal_inflammation | 1.28292651 |
| 77 | MP0001529_abnormal_vocalization | 1.27986905 |
| 78 | MP0009840_abnormal_foam_cell | 1.27498449 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.26102935 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.25690403 |
| 81 | MP0002229_neurodegeneration | 1.21178627 |
| 82 | MP0004742_abnormal_vestibular_system | 1.19986079 |
| 83 | MP0009764_decreased_sensitivity_to | 1.19917008 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.17612551 |
| 85 | MP0003045_fibrosis | 1.17024865 |
| 86 | MP0003632_abnormal_nervous_system | 1.16422511 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.16155185 |
| 88 | MP0002405_respiratory_system_inflammati | 1.12848115 |
| 89 | MP0000716_abnormal_immune_system | 1.12124435 |
| 90 | MP0001765_abnormal_ion_homeostasis | 1.09464619 |
| 91 | MP0008872_abnormal_physiological_respon | 1.08241449 |
| 92 | MP0000569_abnormal_digit_pigmentation | 1.08205571 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 1.07995524 |
| 94 | MP0003878_abnormal_ear_physiology | 1.07995524 |
| 95 | MP0006276_abnormal_autonomic_nervous | 1.07148134 |
| 96 | MP0008874_decreased_physiological_sensi | 1.06807386 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.06691638 |
| 98 | MP0001545_abnormal_hematopoietic_system | 1.06691638 |
| 99 | MP0005076_abnormal_cell_differentiation | 1.06494634 |
| 100 | MP0002152_abnormal_brain_morphology | 1.05704840 |
| 101 | MP0008004_abnormal_stomach_pH | 1.02890478 |
| 102 | MP0005670_abnormal_white_adipose | 1.02455071 |
| 103 | MP0003787_abnormal_imprinting | 1.01892428 |
| 104 | MP0002398_abnormal_bone_marrow | 0.97985619 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.97522835 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.95714691 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.95517666 |
| 108 | MP0008469_abnormal_protein_level | 0.91019331 |
| 109 | MP0001984_abnormal_olfaction | 0.90472249 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.90307792 |
| 111 | MP0000678_abnormal_parathyroid_gland | 0.89480166 |
| 112 | MP0001873_stomach_inflammation | 0.88184387 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.86502879 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.86362269 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.85338406 |
| 116 | MP0000858_altered_metastatic_potential | 0.83179583 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.82305783 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.80681980 |
| 119 | MP0002429_abnormal_blood_cell | 0.77828318 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.77721801 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.77642028 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.76868813 |
| 123 | MP0005409_darkened_coat_color | 0.76278710 |
| 124 | MP0005535_abnormal_body_temperature | 0.75748388 |
| 125 | MP0001177_atelectasis | 0.72844793 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.72010225 |
| 127 | MP0002090_abnormal_vision | 0.67322217 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.65789566 |
| 129 | MP0005310_abnormal_salivary_gland | 0.65251749 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.64931777 |
| 131 | MP0005166_decreased_susceptibility_to | 0.64167708 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.63343171 |
| 133 | MP0001664_abnormal_digestion | 0.57192887 |
| 134 | MP0003283_abnormal_digestive_organ | 0.56649444 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.55656854 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.55086692 |
| 137 | MP0005499_abnormal_olfactory_system | 0.55086692 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.54323978 |
| 139 | MP0000751_myopathy | 0.51282499 |
| 140 | MP0000747_muscle_weakness | 0.50651242 |
| 141 | MP0004145_abnormal_muscle_electrophysio | 0.50632860 |
| 142 | MP0005410_abnormal_fertilization | 0.50448077 |
| 143 | MP0004085_abnormal_heartbeat | 0.50360823 |
| 144 | MP0001943_abnormal_respiration | 0.48123429 |
| 145 | MP0010769_abnormal_survival | 0.47200691 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.47132023 |
| 147 | MP0003956_abnormal_body_size | 0.46430713 |
| 148 | MP0003861_abnormal_nervous_system | 0.45158066 |
| 149 | MP0004043_abnormal_pH_regulation | 0.43809743 |
| 150 | MP0000015_abnormal_ear_pigmentation | 0.43479123 |
| 151 | MP0010386_abnormal_urinary_bladder | 0.43262739 |
| 152 | MP0010768_mortality/aging | 0.43243680 |
| 153 | MP0010770_preweaning_lethality | 0.43207976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.19847058 |
| 2 | Focal motor seizures (HP:0011153) | 6.12000254 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 5.22723466 |
| 4 | Visual hallucinations (HP:0002367) | 5.04433615 |
| 5 | Focal seizures (HP:0007359) | 5.02693733 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.94474228 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.68461299 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.48828384 |
| 9 | Ankle clonus (HP:0011448) | 4.34309302 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.26457092 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.23669988 |
| 12 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.15292402 |
| 13 | Action tremor (HP:0002345) | 4.08737248 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 4.04021055 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.96527867 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.92386239 |
| 17 | Mutism (HP:0002300) | 3.88937862 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.83599329 |
| 19 | Atonic seizures (HP:0010819) | 3.79871413 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.78649749 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 3.72091012 |
| 22 | Papilledema (HP:0001085) | 3.61779721 |
| 23 | Spastic gait (HP:0002064) | 3.50288910 |
| 24 | Dysmetria (HP:0001310) | 3.48066615 |
| 25 | Insidious onset (HP:0003587) | 3.47795106 |
| 26 | Termporal pattern (HP:0011008) | 3.47795106 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.43955625 |
| 28 | Absence seizures (HP:0002121) | 3.35751143 |
| 29 | Urinary urgency (HP:0000012) | 3.34685246 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.31298511 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 3.29903372 |
| 32 | Febrile seizures (HP:0002373) | 3.24021064 |
| 33 | Broad-based gait (HP:0002136) | 3.23659934 |
| 34 | Dialeptic seizures (HP:0011146) | 3.22574413 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22331218 |
| 36 | Poor eye contact (HP:0000817) | 3.21431544 |
| 37 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.11254657 |
| 38 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.11254657 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.11123426 |
| 40 | Intention tremor (HP:0002080) | 3.11093298 |
| 41 | Myositis (HP:0100614) | 3.08913834 |
| 42 | Postural instability (HP:0002172) | 3.08227627 |
| 43 | Diplopia (HP:0000651) | 3.04387026 |
| 44 | Abnormality of binocular vision (HP:0011514) | 3.04387026 |
| 45 | Orchitis (HP:0100796) | 3.02533285 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.97246575 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96632963 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96632963 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96632963 |
| 50 | Depression (HP:0000716) | 2.94860735 |
| 51 | Impaired social interactions (HP:0000735) | 2.92827953 |
| 52 | Abnormal social behavior (HP:0012433) | 2.92827953 |
| 53 | Gaze-evoked nystagmus (HP:0000640) | 2.92170255 |
| 54 | Dysdiadochokinesis (HP:0002075) | 2.89390573 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.86926851 |
| 56 | Optic neuritis (HP:0100653) | 2.86926851 |
| 57 | Dysmetric saccades (HP:0000641) | 2.85542054 |
| 58 | Truncal ataxia (HP:0002078) | 2.83942390 |
| 59 | Akinesia (HP:0002304) | 2.80156436 |
| 60 | Loss of speech (HP:0002371) | 2.77998840 |
| 61 | Progressive inability to walk (HP:0002505) | 2.72893257 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72625153 |
| 63 | Obstructive lung disease (HP:0006536) | 2.72625153 |
| 64 | Increased IgE level (HP:0003212) | 2.71300739 |
| 65 | Amyotrophic lateral sclerosis (HP:0007354) | 2.67909835 |
| 66 | Gingivitis (HP:0000230) | 2.67656084 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.67468648 |
| 68 | Apathy (HP:0000741) | 2.66856631 |
| 69 | Scanning speech (HP:0002168) | 2.64188954 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.63087391 |
| 71 | Lower limb muscle weakness (HP:0007340) | 2.62566117 |
| 72 | Stomatitis (HP:0010280) | 2.62414668 |
| 73 | Anxiety (HP:0000739) | 2.62411630 |
| 74 | Peripheral hypomyelination (HP:0007182) | 2.59734741 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.58001245 |
| 76 | Torticollis (HP:0000473) | 2.57716946 |
| 77 | Megalencephaly (HP:0001355) | 2.53645746 |
| 78 | Limb dystonia (HP:0002451) | 2.53260742 |
| 79 | Hyperventilation (HP:0002883) | 2.49736599 |
| 80 | Amblyopia (HP:0000646) | 2.49400991 |
| 81 | Onion bulb formation (HP:0003383) | 2.47310130 |
| 82 | Axonal loss (HP:0003447) | 2.47234020 |
| 83 | Bradykinesia (HP:0002067) | 2.47020797 |
| 84 | Pheochromocytoma (HP:0002666) | 2.45883611 |
| 85 | Dementia (HP:0000726) | 2.45495154 |
| 86 | Amyloidosis (HP:0011034) | 2.44934506 |
| 87 | Stereotypic behavior (HP:0000733) | 2.42579492 |
| 88 | Hemiparesis (HP:0001269) | 2.42214841 |
| 89 | Recurrent skin infections (HP:0001581) | 2.41852600 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.41758409 |
| 91 | Impaired smooth pursuit (HP:0007772) | 2.41599998 |
| 92 | Cellulitis (HP:0100658) | 2.41304867 |
| 93 | Inappropriate behavior (HP:0000719) | 2.40900172 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.40261040 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.39079099 |
| 96 | Spastic tetraparesis (HP:0001285) | 2.39042142 |
| 97 | Abnormality of the lower motor neuron (HP:0002366) | 2.38826428 |
| 98 | Diminished motivation (HP:0000745) | 2.36397192 |
| 99 | Clonus (HP:0002169) | 2.35812170 |
| 100 | Focal dystonia (HP:0004373) | 2.35231113 |
| 101 | Meningitis (HP:0001287) | 2.34692399 |
| 102 | Drooling (HP:0002307) | 2.34056176 |
| 103 | Excessive salivation (HP:0003781) | 2.34056176 |
| 104 | Genetic anticipation (HP:0003743) | 2.32796225 |
| 105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31132227 |
| 106 | Generalized myoclonic seizures (HP:0002123) | 2.29796643 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29017945 |
| 108 | Recurrent fungal infections (HP:0002841) | 2.25409161 |
| 109 | Insomnia (HP:0100785) | 2.22429807 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 2.21030505 |
| 111 | Malnutrition (HP:0004395) | 2.19113633 |
| 112 | Hemiplegia (HP:0002301) | 2.19108067 |
| 113 | Hemorrhage of the eye (HP:0011885) | 2.18541633 |
| 114 | Polyphagia (HP:0002591) | 2.17746072 |
| 115 | Rigidity (HP:0002063) | 2.16998532 |
| 116 | Craniofacial dystonia (HP:0012179) | 2.15633481 |
| 117 | Rapidly progressive (HP:0003678) | 2.15280833 |
| 118 | Disinhibition (HP:0000734) | 2.14775001 |
| 119 | Annular pancreas (HP:0001734) | 2.14708006 |
| 120 | Abnormality of saccadic eye movements (HP:0000570) | 2.13867198 |
| 121 | Absent speech (HP:0001344) | 2.12530685 |
| 122 | Lower limb amyotrophy (HP:0007210) | 2.11389480 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10992055 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10992055 |
| 125 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10992055 |
| 126 | Obstructive sleep apnea (HP:0002870) | 2.08795603 |
| 127 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.06259204 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05840849 |
| 129 | Mucopolysacchariduria (HP:0008155) | 2.05840849 |
| 130 | Gastrointestinal infarctions (HP:0005244) | 2.05796523 |
| 131 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.05634507 |
| 132 | Abnormality of the fingertips (HP:0001211) | 2.04282708 |
| 133 | Slow saccadic eye movements (HP:0000514) | 2.04060723 |
| 134 | Impaired vibratory sensation (HP:0002495) | 2.04027577 |
| 135 | Neuroendocrine neoplasm (HP:0100634) | 2.03620570 |
| 136 | Vasculitis (HP:0002633) | 2.03396987 |
| 137 | Colitis (HP:0002583) | 2.01212157 |
| 138 | Inability to walk (HP:0002540) | 1.99723759 |
| 139 | Psychosis (HP:0000709) | 1.99654146 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.96481047 |
| 141 | Delusions (HP:0000746) | 1.95930733 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.95790359 |
| 143 | Ventricular fibrillation (HP:0001663) | 1.94551069 |
| 144 | Keratoconjunctivitis sicca (HP:0001097) | 1.94067866 |
| 145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92534394 |
| 146 | Hammertoe (HP:0001765) | 1.92101328 |
| 147 | Clumsiness (HP:0002312) | 1.92064075 |
| 148 | Retinal dysplasia (HP:0007973) | 1.90963442 |
| 149 | Progressive visual loss (HP:0000529) | 1.90606552 |
| 150 | Gait ataxia (HP:0002066) | 1.90067584 |
| 151 | Resting tremor (HP:0002322) | 1.89490275 |
| 152 | Fetal akinesia sequence (HP:0001989) | 1.88844528 |
| 153 | Memory impairment (HP:0002354) | 1.88584627 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.87836958 |
| 155 | Hypsarrhythmia (HP:0002521) | 1.87760102 |
| 156 | Urticaria (HP:0001025) | 1.84982818 |
| 157 | Hemoptysis (HP:0002105) | 1.80591775 |
| 158 | Personality changes (HP:0000751) | 1.80239024 |
| 159 | Dysautonomia (HP:0002459) | 1.79851372 |
| 160 | Pustule (HP:0200039) | 1.77890336 |
| 161 | Encephalitis (HP:0002383) | 1.77237524 |
| 162 | Keratoconjunctivitis (HP:0001096) | 1.76609622 |
| 163 | Episodic fever (HP:0001954) | 1.75596378 |
| 164 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74606686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.26953532 |
| 2 | MARK1 | 3.71819241 |
| 3 | EPHA4 | 3.70993983 |
| 4 | NTRK3 | 3.33144727 |
| 5 | TRIB3 | 2.81095850 |
| 6 | DAPK2 | 2.74928640 |
| 7 | MINK1 | 2.61442771 |
| 8 | PAK6 | 2.56661901 |
| 9 | KSR2 | 2.54665062 |
| 10 | MAP4K1 | 2.46674630 |
| 11 | MAP3K4 | 2.45299908 |
| 12 | SIK1 | 2.34662333 |
| 13 | NTRK1 | 2.27922479 |
| 14 | IRAK3 | 2.26372845 |
| 15 | RIPK4 | 2.22418967 |
| 16 | MAP2K7 | 1.95982485 |
| 17 | ERN1 | 1.93684118 |
| 18 | CAMKK1 | 1.90465874 |
| 19 | MAP3K11 | 1.88679221 |
| 20 | PRKD3 | 1.86232941 |
| 21 | NTRK2 | 1.84824220 |
| 22 | BLK | 1.82769431 |
| 23 | CDK19 | 1.66740125 |
| 24 | CDK5 | 1.65435958 |
| 25 | DDR2 | 1.62142032 |
| 26 | IRAK4 | 1.61859029 |
| 27 | MAP3K13 | 1.56349153 |
| 28 | MAP2K4 | 1.52234194 |
| 29 | MAP3K12 | 1.47173682 |
| 30 | TYK2 | 1.47051558 |
| 31 | DAPK1 | 1.46600037 |
| 32 | FES | 1.46538873 |
| 33 | GRK5 | 1.44364473 |
| 34 | OXSR1 | 1.43740593 |
| 35 | SIK3 | 1.42976169 |
| 36 | PRPF4B | 1.39710071 |
| 37 | CSK | 1.39305249 |
| 38 | TAOK2 | 1.37453554 |
| 39 | MST1R | 1.34440090 |
| 40 | SIK2 | 1.32795709 |
| 41 | TYRO3 | 1.30622030 |
| 42 | UHMK1 | 1.29375058 |
| 43 | MAP3K2 | 1.29098287 |
| 44 | ARAF | 1.26213351 |
| 45 | STK39 | 1.21962715 |
| 46 | CASK | 1.20165047 |
| 47 | MAP2K3 | 1.20119789 |
| 48 | IRAK2 | 1.18987256 |
| 49 | PHKG2 | 1.17998325 |
| 50 | PHKG1 | 1.17998325 |
| 51 | KSR1 | 1.16144119 |
| 52 | PNCK | 1.13991098 |
| 53 | TNIK | 1.13666194 |
| 54 | TBK1 | 1.13492576 |
| 55 | ALK | 1.10978944 |
| 56 | PKN1 | 1.09625697 |
| 57 | MAPK13 | 1.09376338 |
| 58 | PLK2 | 1.09227402 |
| 59 | FGR | 1.08342841 |
| 60 | ZAP70 | 1.07890349 |
| 61 | RET | 1.06446563 |
| 62 | TAOK1 | 1.04400413 |
| 63 | CDK15 | 1.04337586 |
| 64 | CAMK1D | 1.03195946 |
| 65 | CDK14 | 1.02503846 |
| 66 | CDK18 | 1.01719000 |
| 67 | STK11 | 1.00817677 |
| 68 | MAP3K3 | 0.99137029 |
| 69 | MATK | 0.98957203 |
| 70 | SMG1 | 0.96271503 |
| 71 | BTK | 0.95959730 |
| 72 | ACVR1B | 0.94368338 |
| 73 | CDC42BPA | 0.93545064 |
| 74 | CAMKK2 | 0.93390162 |
| 75 | CDK11A | 0.91883750 |
| 76 | MARK2 | 0.89397317 |
| 77 | PRKCG | 0.89125563 |
| 78 | PRKG2 | 0.89014435 |
| 79 | SYK | 0.88998396 |
| 80 | MARK3 | 0.88888023 |
| 81 | LIMK1 | 0.88857914 |
| 82 | PRKD2 | 0.88745978 |
| 83 | CSNK1G2 | 0.88705284 |
| 84 | JAK1 | 0.87684722 |
| 85 | HCK | 0.87234717 |
| 86 | MAPKAPK5 | 0.87118824 |
| 87 | CSF1R | 0.83941347 |
| 88 | STK38 | 0.81756583 |
| 89 | SGK494 | 0.80691302 |
| 90 | SGK223 | 0.80691302 |
| 91 | PDPK1 | 0.80598933 |
| 92 | PDK1 | 0.80442315 |
| 93 | TESK1 | 0.79080986 |
| 94 | RAF1 | 0.78602128 |
| 95 | IKBKE | 0.77819965 |
| 96 | WNK1 | 0.77736435 |
| 97 | PRKCH | 0.76954862 |
| 98 | CAMK2A | 0.76112476 |
| 99 | EPHA2 | 0.76083487 |
| 100 | CAMK2B | 0.75546097 |
| 101 | LATS2 | 0.74799407 |
| 102 | MAP2K6 | 0.72310732 |
| 103 | DAPK3 | 0.71087711 |
| 104 | CAMK1 | 0.69602979 |
| 105 | SCYL2 | 0.69135176 |
| 106 | MAP3K14 | 0.67146556 |
| 107 | TXK | 0.66985099 |
| 108 | RIPK1 | 0.66146412 |
| 109 | JAK2 | 0.64712366 |
| 110 | FYN | 0.64501352 |
| 111 | MAP3K1 | 0.63959035 |
| 112 | LMTK2 | 0.63845245 |
| 113 | PAK3 | 0.62676444 |
| 114 | LYN | 0.60812247 |
| 115 | HIPK2 | 0.58094261 |
| 116 | IKBKB | 0.56847530 |
| 117 | SGK1 | 0.55706978 |
| 118 | JAK3 | 0.55526627 |
| 119 | PRKCZ | 0.55385449 |
| 120 | CAMK1G | 0.54721588 |
| 121 | CDK12 | 0.54057694 |
| 122 | ICK | 0.53697251 |
| 123 | LCK | 0.53461591 |
| 124 | PTK6 | 0.53227514 |
| 125 | PTK2B | 0.52965640 |
| 126 | KIT | 0.52130543 |
| 127 | ROCK2 | 0.51726721 |
| 128 | EPHB1 | 0.47643608 |
| 129 | TNK2 | 0.47468542 |
| 130 | TESK2 | 0.46777865 |
| 131 | DYRK1A | 0.46014224 |
| 132 | CSNK1G3 | 0.45329071 |
| 133 | MAP3K7 | 0.45271437 |
| 134 | ITK | 0.45017479 |
| 135 | BMPR2 | 0.44076402 |
| 136 | TAOK3 | 0.43967637 |
| 137 | PKN2 | 0.43684562 |
| 138 | DYRK2 | 0.42494683 |
| 139 | BMX | 0.42378671 |
| 140 | CAMK4 | 0.42081028 |
| 141 | CAMK2G | 0.41457546 |
| 142 | MAPK10 | 0.41321031 |
| 143 | RPS6KC1 | 0.40673557 |
| 144 | RPS6KL1 | 0.40673557 |
| 145 | RPS6KA3 | 0.40156787 |
| 146 | CAMK2D | 0.39757534 |
| 147 | RPS6KA6 | 0.39050130 |
| 148 | MAP3K6 | 0.38263914 |
| 149 | GRK6 | 0.37864012 |
| 150 | PINK1 | 0.37752249 |
| 151 | MAPK12 | 0.33841662 |
| 152 | CSNK1A1L | 0.33232574 |
| 153 | RPS6KA2 | 0.33192667 |
| 154 | SGK3 | 0.29867185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27135204 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85092762 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60953097 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47928215 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45343080 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45011561 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42831456 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.37786436 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.33154242 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.31482009 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.06995466 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04649248 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04578547 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02210399 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00426533 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92898655 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91232381 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87813228 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.77624077 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71337212 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.68611903 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67729690 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64300145 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.58254050 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57724970 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.57331778 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57066770 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56201458 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.53680953 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53481644 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45104474 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44415078 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44009964 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.41397425 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.41052709 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40642850 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.33454540 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32832917 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32660659 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.30227753 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.27179241 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26444882 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25955900 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.22168584 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19181965 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18008277 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17799735 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16536286 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15994073 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14511812 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12534838 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11237362 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07639549 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06035276 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02640626 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99397626 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98123426 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96221983 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95540345 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95185124 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.94909258 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94891894 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94754329 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.94432098 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93418336 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93351487 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92998758 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92334864 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91146248 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.90160679 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90050806 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89448142 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.87081869 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85604005 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85208051 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85019673 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84265740 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83981864 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83739150 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.83233809 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81498952 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80912781 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80389458 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79809533 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79577892 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78148617 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77991824 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76188149 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.75883986 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74772535 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74494091 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73758505 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72321390 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70345288 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66440125 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66205380 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65816985 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64753923 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62208592 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61488216 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60098639 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58686129 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.58313650 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58233623 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58220649 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57500362 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56889932 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56752804 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56563377 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54760496 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54290902 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54005194 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.53967242 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53219219 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.52948875 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50239773 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48848898 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47420610 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46654969 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46083229 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45818619 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.45622199 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.45231640 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44283511 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.42724355 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.41469653 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41378407 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41158409 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41101948 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40336414 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.39676541 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.37625645 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.37402993 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.37132085 |
| 135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36044492 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35594554 |

